Naturhouse Health (XMAD:NTH) Growth Rank: 2 (As of Aug. 06, 2026) — 100% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAD:NTH Naturhouse Health SA XMAD:NTH
72 GF Score
Price €2.57
GF Value €1.62
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Naturhouse Health Growth Rank?

Naturhouse Health XMAD:NTH 72 Growth Rank is 2 as of Aug. 06, 2026, which is 100% above its 10-year median of 1.00. GuruFocus rates XMAD:NTH with a GF Score™ of 72/100 and a GF Value™ of €1.62 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Naturhouse Health has the Growth Rank of 2.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Naturhouse Health Growth Rank Related Terms

XMAD:NTH vs KHC, GIS, HRL: Growth Rank Comparison

For the Packaged Foods subindustry, Naturhouse Health's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Naturhouse Health Growth Rank vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Naturhouse Health's Growth Rank distribution charts can be found below:

* The bar in red indicates where Naturhouse Health's Growth Rank falls into.


XMAD:NTH
72GF Score
Naturhouse Health SA XMAD:NTH
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 2 mean?
Naturhouse Health (XMAD:NTH) has a Growth Rank of 2 as of Aug. 06, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Naturhouse Health and its competitors. This is 100% above median its historical median of 1.00. Over the past decade, Naturhouse Health's Growth Rank has ranged from 1.00 to 4.00.
Is Naturhouse Health's Growth Rank too high?
Naturhouse Health's current Growth Rank of 2 is 100% above median its 10-year median of 1.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 4.00. Overall, Naturhouse Health has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's Growth Rank compare to KHC and GIS?
Naturhouse Health's Growth Rank of 2 can be compared against companies in the Consumer Packaged Goods industry. Historically, Naturhouse Health's own Growth Rank has ranged from 1.00 to 4.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Consumer Packaged Goods company?
A good Growth Rank depends on the Consumer Packaged Goods industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Naturhouse Health and its competitors. Naturhouse Health's current Growth Rank is 2, which is 100% above median its own 10-year median of 1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €2.57 — trading 58.6% above its estimated fair value. The current Growth Rank is 2, which is 100% above median its 10-year median of 1.00. Naturhouse Health's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current Growth Rank is 2 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?

Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued. The current stock price of €2.57 is trading 58.6% above its estimated GF Value™ of €1.62. GuruFocus considers Naturhouse Health to be Significantly Overvalued.

Key valuation signals for XMAD:NTH:

  • Growth Rank: 2 (100% above median its 10-year median of 1.00)
  • GF Value™: €1.62 vs. price of €2.57 (58.6% above fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Naturhouse Health Business Description

Other Exchanges 0R9G:UK2NH:Germany
Address Calle Claudio Coello, 91, 4º Planta, Madrid, ESP, 28006
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
72GF Score

Get the complete analysis for XMAD:NTH

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.57
Price
€1.62
GF Value